|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.220 USD | -0.38% |
|
+1.95% | -36.19% |
| Mar. 12 | Helus Pharma Announces Appointment of Jill Conwell as Chief People Officer, Effective on March 12, 2026 | CI |
| Mar. 06 | Cybin Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYBIN INC. | Bio Therapeutic Drugs | -0.38% | +1.95% | -36.19% | -23.24% | -89.75% | 261M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- HELP Stock
- Charts Cybin Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
